Home

Cigna Corp (CI)

315.99
+3.31 (1.06%)
NYSE · Last Trade: May 25th, 4:58 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Microsoft Clears Major Hurdle As FTC Ends Effort To Block Activision Mergerbenzinga.com
The Ninth Circuit affirmed a decision denying the FTC's application to block Microsoft's acquisition of Activision Blizzard. The FTC dropped the case and Trump's personnel changes may impact future tech regulation and antitrust enforcement.
Via Benzinga · May 23, 2025
FTC Scraps PepsiCo Price Discrimination Case In 3-0 Vote, Marking Major Shift As Trump-Era Leadership Reverses Biden Crackdownbenzinga.com
The Federal Trade Commission voted 3-0 Thursday to dismiss a lawsuit against PepsiCo Inc. that accused the beverage giant of offering preferential pricing to major retailers, marking a significant shift from Biden-era corporate scrutiny under the new Trump administration.
Via Benzinga · May 23, 2025
Why Hims & Hers Health (HIMS) Stock Is Falling Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna Group's Evernorth division introduced a monthly $200 price cap for weight-loss medications such as Wegovy and Zepbound, a move that could significantly disrupt pricing in the weight loss drug market. 
Via StockStory · May 22, 2025
Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dullstocktwits.com
Truist noted on Thursday that the $200/month price point is "highly attractive compared to other price points in the market," including Hims & Hers' compounded Semaglutide, Wegovy, and Liraglutide subscription programs.
Via Stocktwits · May 22, 2025
Wegovy, Zepbound Just Got Cheaper: Cigna Sets $200 Monthly Limit For Weight-Loss Drug Usersstocktwits.com
Cigna’s Evernorth has reached agreements with Eli Lilly and Novo Nordisk to reduce prices for GLP-1 weight-loss drugs Wegovy and Zepbound
Via Stocktwits · May 22, 2025
Humana, UnitedHealth, CVS Slide As CMS Targets Medicare Overpayments In ‘Aggressive’ Audit Planstocktwits.com
US healthcare stocks came under pressure after CMS said it would expand Medicare Advantage audits and partner with the HHS Inspector General to recover past overpayments.
Via Stocktwits · May 21, 2025
Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Yearsbenzinga.com
Via Benzinga · May 20, 2025
What's going on in today's pre-market session: S&P500 moverschartmill.com
Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.
Via Chartmill · May 20, 2025
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortionbenzinga.com
Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.
Via Benzinga · May 19, 2025
Discover which S&P500 stocks are making waves on Friday.chartmill.com
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.
Via Chartmill · May 16, 2025
CI Q1 Earnings Call: Cigna Delivers Revenue Beat and Focuses on Healthcare Innovation
Health insurance company Cigna (NYSE:CI) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 14.4% year on year to $65.5 billion. Its non-GAAP profit of $6.74 per share was 6.2% above analysts’ consensus estimates.
Via StockStory · May 16, 2025
Texas Rep. Julie Johnson Sold Up to $2.29M Worth of Amazon.com Stockbenzinga.com
Via Benzinga · May 15, 2025
Top S&P500 movers in Tuesday's sessionchartmill.com
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.
Via Chartmill · May 13, 2025
Stay informed with the top movers within the S&P500 index on Tuesday.chartmill.com
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · May 13, 2025
Trump Again Promises Lower Drug Prices By 'Cutting Out Middlemen' Like UnitedHealth, CVS: Will It Work This Time?benzinga.com
Bernie Sanders wonders if Trump is "serious about making real change rather than just issuing a press release."
Via Benzinga · May 13, 2025
CVS Health, Cigna Stocks Dip Tuesday: What's Going On?benzinga.com
Trump on Monday signed an executive order aimed at reducing the cost of prescription drugs.
Via Benzinga · May 13, 2025
Why Cigna Group Stock Dived Todayfool.com
Via The Motley Fool · May 12, 2025
Monday's session: top gainers and losers in the S&P500 indexchartmill.com
Curious about the top performers within the S&P500 index one hour before the close of the markets on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · May 12, 2025
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.chartmill.com
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.
Via Chartmill · May 12, 2025
These S&P500 stocks are moving in today's sessionchartmill.com
Get insights into the S&P500 index performance on Monday. Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill · May 12, 2025
Monday's session: gap up and gap down stock in the S&P500 indexchartmill.com
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Monday. Stay informed about the latest market trends.
Via Chartmill · May 12, 2025
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · May 9, 2025
1 Cash-Producing Stock with Solid Fundamentals and 2 to Ignore
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Via StockStory · May 9, 2025
1 Hated Stock that Deserves a Second Chance and 2 to Avoid
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Via StockStory · May 6, 2025
Cigna Packs Healthy Punch As Q1 Beat Sends Shares Higher, Analysts Raise Targetsbenzinga.com
Shares of Cigna Group (CI) rose on Monday after announcing upbeat Q1 results. Analysts are optimistic about the company's growth and raised guidance.
Via Benzinga · May 5, 2025